DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
44 hedge funds and large institutions have $3.3M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
44
Holding in Top 10
–
Calls
$271K
Puts
–
Top Buyers
| 1 | +$2.01M | |
| 2 | +$116K | |
| 3 | +$56.8K | |
| 4 |
CAC
Cowen and Company
New York
|
+$50.2K |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$34K |
Top Sellers
| 1 | -$974K | |
| 2 | -$720K | |
| 3 | -$380K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$355K |
| 5 |
ClearBridge Investments
New York
|
-$351K |